Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | EVP & Chief Financial Officer | July 03, 2026 | July 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date July 03, 2026 · Filed July 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 45,263 |
Reported balance
After 2026-07-03 transaction · row 1
1 source rowRow 1 · 2026-07-03 · Tax withholding · Disposed 5,226 · Balance 45,263 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 03, 2026 Filed Jul 6, 2026 20:40 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 5,226 | $18.05 | $94,329.30 |
DisclosureSEC source: 0001983748-26-000003 · wk-form4_1783370404.xml · nonDerivative · entry 1 Knight Lea Daniels · CIK 0001983748 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,263 Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantRestricted Stock Units · Derivative | 111,179 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001983748-26-000001 · wk-form4_1773350177.xml · derivative · entry 2 Knight Lea Daniels · CIK 0001983748 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,179 Underlying: Common Stock · 111,179 shares Expires not disclosed F1 · derivative.exercise_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. F1 · derivative.expiration_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 8,089 | $9.61 | $77,735.29 |
DisclosureSEC source: 0001983748-26-000001 · wk-form4_1773350177.xml · nonDerivative · entry 1 Knight Lea Daniels · CIK 0001983748 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,489 Read SEC document |
| July 03, 2025 Filed Jul 7, 2025 21:06 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 2,561 | $13.49 | $34,547.89 |
DisclosureSEC source: 0000917520-25-000063 · wk-form4_1751922402.xml · nonDerivative · entry 1 Knight Lea Daniels · CIK 0001983748 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,578 Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:30 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon- Qualified Stock Option (right to buy) · Derivative | 44,171 | $0.00 Strike: $23.95 | $0.00 |
DisclosureSEC source: 0000917520-25-000028 · wk-form4_1741897803.xml · derivative · entry 3 Knight Lea Daniels · CIK 0001983748 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,171 Underlying: Non-Qualified Stock Option (right to buy) · 44,171 shares Expires 2033-03-11 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2025. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:30 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 20,859 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-25-000028 · wk-form4_1741897803.xml · nonDerivative · entry 2 Knight Lea Daniels · CIK 0001983748 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,139 Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:30 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,655 | $23.95 | $39,637.25 |
DisclosureSEC source: 0000917520-25-000028 · wk-form4_1741897803.xml · nonDerivative · entry 1 Knight Lea Daniels · CIK 0001983748 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,280 Read SEC document |
| July 03, 2024 Filed Jul 5, 2024 20:09 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 2,561 | $28.73 | $73,577.53 |
DisclosureSEC source: 0000917520-24-000087 · wk-form4_1720210168.xml · nonDerivative · entry 1 Knight Lea Daniels · CIK 0001983748 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,935 Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:26 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon- Qualified Stock Option (right to buy) · Derivative | 27,308 | $0.00 Strike: $36.22 | $0.00 |
DisclosureSEC source: 0000917520-24-000032 · wk-form4_1710361600.xml · derivative · entry 3 Knight Lea Daniels · CIK 0001983748 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,308 Underlying: Common Stock · 27,308 shares Expires 2032-03-11 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2024. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:26 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 8,283 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-24-000032 · wk-form4_1710361600.xml · nonDerivative · entry 2 Knight Lea Daniels · CIK 0001983748 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,496 Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:26 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 11,822 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-24-000032 · wk-form4_1710361600.xml · nonDerivative · entry 1 Knight Lea Daniels · CIK 0001983748 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,213 Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 20:10 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 6,098 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-017117 · doc4.xml · nonDerivative · entry 2 Knight Lea Daniels · CIK 0001983748 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,391 Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 20:10 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 18,293 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-017117 · doc4.xml · nonDerivative · entry 1 Knight Lea Daniels · CIK 0001983748 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,293 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.